Biological versus chronological ovarian age: implications for assisted reproductive technology

2009161 citationsReviewgold Open Access

Authors

Carlo Alviggi · University of Naples Federico II

Colin M. Howles · Merck Serono (Switzerland)

Stephen G. Hillier · MRC Centre for Reproductive Health

Abstract

Patients with biologically older ovaries may benefit from a tailored approach based on individual patient characteristics. Among the most promising adjuvant therapies for improving ART outcomes in women of advanced reproductive age are the administration of exogenous LH or GH.

Topics & Keywords

Reproductive Biology and Fertility Ovarian function and disorders Assisted Reproductive Technology and Twin Pregnancy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Reproductive Biology and Endocrinology

Volume 7, Issue 1, pp. 101-101

DOI: 10.1186/1477-7827-7-101

Field-Weighted Citation Impact: 8.18